Keta patient Dr. Jim Ellwood shares his personal journey with treatment-resistant depression and how he found lasting relief with ketamine therapy. Here’s his story.
Keta patient Dr. Jim Ellwood shares his personal journey with treatment-resistant depression and how he found lasting relief with ketamine therapy. Here’s his story.
Ketamine therapy offers new hope for patients with treatment-resistant depression, PTSD, OCD, and other conditions, but careful candidate selection is essential. Learn which factors determine eligibility, what contraindications to watch for, and why a thorough medical evaluation is the foundation of safe, effective treatment.
The April 2026 executive order marks one of the most significant federal shifts in mental health policy in decades. Here's what it actually does, what it doesn't, and what it could mean for the future of psychedelic-assisted therapy.
Psilocybin therapy is moving closer to mainstream medicine, but the legal picture is more complicated than recent headlines suggest. We break down federal vs. state law, the impact of the 2026 executive order, and what patients can access right now.
Paul Rosales, Patient Experience Liaison at Keta Medical Center, shares how our practice supports the LGBTQ+ community, not just during Pride Month, but all year long.
In recognition of Mental Health Awareness Month, this article is shared in appreciation of the National Association of Social Workers (NASW) and all of the professional providers who serve on the front lines of care.
Ketamine IV and Spravato are innovative medical treatments to address mental health conditions, and many people want to know what to expect before their first session.